Skip to content

SEPN

Septerna, Inc.

NASDAQ · USHealthcareBiotechnology
$32.21-3.56%

Price as of Jul 20, 2026

SEPN capital

Septerna, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.06x
Net debt / equity
-0.13x
Debt / assets
0.04x
Debt / EBITDA
-0.44x
Net debt / EBITDA
0.93x

Liquidity & coverage

Current ratio
4.71x
Quick ratio
4.71x
Cash ratio
4.44x
Interest coverage
EBITDA / interest
Working capital
$289.9M

Cash & dividend

FCF / debt
4.63x
Cash flow / debt
4.67x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.